Skip to content
value.today

Petra Pharma Corp

🇺🇸 New York, New York, USABiotechnologyFounded 2015
Total raised
$59 M
2 rounds on record
Latest round
$28 M
Aug 2018
First round on record
Dec 2015
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Petra Pharma Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2018$28 MNo. 2$10 to $50 million

Petra Pharma Corp: Raise no. 2, Aug 2018

Investors in this round

10 investors had bought by the notice of Mar 31, 2020: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Albert Johnston Yu · Executive Officer
  • Brian Johnston O'Callaghan · Executive Officer, Director
  • David Johnston McElligott · Executive Officer, Promoter
  • David Johnston Renas · Executive Officer
  • Barbara Johnston Dalton · Director
  • Jenna Johnston Foger · Director
  • M. Johnston Erwin · Director
  • Paul Johnston Sekhri · Director
  • Steve Gillis · Director
  • Thong Le · Director, Promoter
  • David Johnston Schubert · Promoter
  • Lindsay Johnston Rayle · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Renas, Chief Financial Officer. Source: SEC Form D and 4 amendments, newest notice filed Mar 31, 2020. Read the notice at the SEC.

debt, optionsSEC
Dec 2015$31 MNo. 1$10 to $50 million

Petra Pharma Corp: Raise no. 1, Dec 2015

Investors in this round

13 investors had bought by the notice of Jan 22, 2018: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $48 M offered; $17 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Albert Johnston Yu · Executive Officer, Promoter
  • Brian Johnston O'Callaghan · Executive Officer, Director
  • David Johnston McElligott · Executive Officer, Promoter
  • David Johnston Renas · Executive Officer
  • Barbara Johnston Dalton · Director
  • Joel Johnston Marcus · Director
  • M. Johnston Erwin · Director
  • Paul Johnston Sekhri · Director
  • Steve Gillis · Director
  • Thong Le · Director, Promoter
  • David Johnston Schubert · Promoter
  • Lindsay Johnston Rayle · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Renas, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Jan 22, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Petra Pharma Corp chose not to state its revenue in its newest notice of a funding round (Mar 2020).

    SEC Form D · Mar 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2020

That is all the official record says: Petra Pharma Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Petra Pharma Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Petra Pharma Corp
NameRoleNamed in
Albert Johnston YuExecutive officerMar 2020
Brian Johnston O'CallaghanExecutive officerMar 2020
David Johnston McElligottExecutive officerMar 2020
David Johnston RenasExecutive officerMar 2020
David Johnston SchubertExecutive officerJan 2017
Lindsay Johnston RayleExecutive officerJan 2017
Thong LeExecutive officerJan 2017
Barbara Johnston DaltonDirectorMar 2020
Brian Johnston O'CallaghanDirectorMar 2020
Jenna Johnston FogerDirectorMar 2020
M. Johnston ErwinDirectorMar 2020
Paul Johnston SekhriDirectorMar 2020
Steve GillisDirectorMar 2020
Thong LeDirectorMar 2020
Joel Johnston MarcusDirectorJan 2018
Asish XavierDirectorJan 2016
James Johnston SullivanDirectorJan 2016
Misti Johnston UshioDirectorJan 2016
David Johnston McElligottPromoterMar 2020
David Johnston SchubertPromoterMar 2020
Lindsay Johnston RaylePromoterMar 2020
Thong LePromoterMar 2020
Albert Johnston YuPromoterJan 2018